poisar

ETF

ARK Genomic Revolution ETF ARKG

$38.07-1.92%

Overview

ARKG market data

Price History

ARKG price chart

Valuation & Profitability

no valuation data
No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for ARKG. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Fund & macro news

8 captured
Cathie Wood Swaps Robinhood for SpaceX, Archer—Did ARK Pivot Back to Moonshot Innovation?Benzinga · Jul 23, 2026, 4:10 PM
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are UnderratingThe Motley Fool · Jul 22, 2026, 11:00 AM
Tempus AI Slides as Investors Weigh $1.5 Billion Personalis AcquisitionBenzinga · Jul 20, 2026, 4:46 PM
Cathie Wood Is Selling This High-Flying Stock. Is It a Buy?The Motley Fool · Jul 20, 2026, 11:01 AM
Why Is Natera Stock Gaining Tuesday?Benzinga · Jun 23, 2026, 5:05 PM
Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETFBenzinga · Jun 18, 2026, 7:05 PM
Cathie Wood, Bill Ackman Share 3 Stock Investments In Common: Can You Guess What They Are?Benzinga · Jun 11, 2026, 8:41 PM
Cathie Wood, Ross Gerber Snap Up The Same 10 Stocks — Here's The Unlikely Portfolio CrossoverBenzinga · May 13, 2026, 6:41 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock